Teva Announces Presentations at Bank Conferences

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live audio webcast at the Morgan Stanley Global Healthcare Conference in New York with William Marth, President and Chief Executive Officer, Teva North America presenting on Monday, September 14, 2009. Eyal Desheh, Chief Financial Officer & Gerard van Odjik, President and CEO, Teva Europe will present on Tuesday, September 15, 2009 in London at the Bank of America Merrill Lynch Global Healthcare Conference.

What:   Teva Presentation at the Morgan Stanley Global Healthcare Conference           Teva Presentation at the Bank of America Merrill Lynch Global
                                                                                       Healthcare Conference
Who:    William Marth, President and Chief Executive Officer, Teva North               Eyal Desheh, Chief Financial Officer
        America                                                                        Gerard van Odjik,
                                                                                       President & CEO, Teva Europe
When:   Monday, September 14, 2009 at 9:45 a.m. ET                                     Tuesday, September 15, 2009 at 1:00 p.m. UKT / 8:00 a.m. ET
Where:  http://www.tevapharm.com/financial/                                            http://www.tevapharm.com/financial/
        or                                                                             or
        http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=TEVA&item_id=2400624  http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=TEVA&item_id=2423787
How:    Live over the Internet -- log on to the Web at the address above and
        register for the event (approx. 10 minutes before). An archive of
        the webcast will be available on Teva's website.

About Teva

Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 20 pharmaceutical companies in the world and is the world's leading generic pharmaceutical company. The Company develops, manufactures and markets generic and innovative human pharmaceuticals and active pharmaceutical ingredients, as well as animal health pharmaceutical products. Over 80 percent of Teva's sales are in North America and Europe.

SOURCE: Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd. 
Elana Holzman, 972 (3) 926-7554 
or 
Teva North America 
Kevin Mannix, 215-591-8912 
www.tevapharm.com

Related terms: animal, bank, ceo, conference, europe, health, healthcare, israel, london, manufacturer, nasdaq, north america, pharmaceuticals, president, products, sales